SELENIUM

SELENIUM was reported 4270 times

SELENIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFRAPATELLAR FAT PAD INFLAMMATION 9 0.4286
1 SELENIUM DEFICIENCY 5 0.1190
2 AUTOPHONY 6 0.0800
3 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 5 0.0625
4 DEAFNESS PERMANENT 12 0.0612
5 ENDOCRINE OPHTHALMOPATHY 39 0.0449
6 ENZYME LEVEL ABNORMAL 5 0.0357
7 ACQUIRED DIAPHRAGMATIC EVENTRATION 12 0.0338
8 LENTIGO MALIGNA 8 0.0299
9 SMALL CELL CARCINOMA 10 0.0291
10 DYSPLASTIC NAEVUS 8 0.0222
11 LIPID METABOLISM DISORDER 8 0.0208
12 MYOSCLEROSIS 6 0.0163
13 OCCIPITAL NEURALGIA 9 0.0159
14 THROAT LESION 10 0.0146
15 SACRAL PAIN 8 0.0132
16 BREAST CALCIFICATIONS 9 0.0113
17 FIBROADENOMA OF BREAST 5 0.0111
18 GENITAL HERPES 17 0.0111
19 ABDOMINAL LYMPHADENOPATHY 9 0.0104
20 DEAFNESS NEUROSENSORY 32 0.0097
21 EFFUSION 12 0.0088
22 CERUMEN IMPACTION 8 0.0087
23 OSTEOCHONDROSIS 10 0.0086
24 NASAL MUCOSAL DISORDER 5 0.0086
25 CAROTID ARTERIOSCLEROSIS 8 0.0078
26 OSTEOSCLEROSIS 12 0.0076
27 MITOCHONDRIAL TOXICITY 6 0.0073
28 CARDIAC HYPERTROPHY 8 0.0072
29 H1N1 INFLUENZA 10 0.0071
30 NOROVIRUS INFECTION 10 0.0069
31 CYSTOCELE 6 0.0069
32 SACROILIITIS 13 0.0069
33 AORTIC CALCIFICATION 4 0.0069
34 BLOOD MAGNESIUM INCREASED 6 0.0067
35 METABOLIC ALKALOSIS 10 0.0062
36 TERMINAL INSOMNIA 11 0.0062
37 COMPLEX REGIONAL PAIN SYNDROME 9 0.0061
38 VERTEBRAL FORAMINAL STENOSIS 5 0.0061
39 MANTLE CELL LYMPHOMA 9 0.0059
40 B-LYMPHOCYTE COUNT DECREASED 8 0.0059
41 GASTROENTERITIS NOROVIRUS 7 0.0053
42 CYSTITIS NONINFECTIVE 7 0.0052
43 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 7 0.0052
44 ORAL MUCOSAL ERYTHEMA 8 0.0052
45 KYPHOSIS 9 0.0051
46 AORTIC DISORDER 4 0.0051
47 HEPATITIS E 8 0.0051
48 PRODUCT CONTAMINATION MICROBIAL 6 0.0050
49 AUDITORY DISORDER 7 0.0049
50 PLEURAL FIBROSIS 5 0.0049
51 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 10 0.0048
52 CHONDROPATHY 13 0.0048
53 INTRADUCTAL PROLIFERATIVE BREAST LESION 6 0.0048
54 SEROMA 6 0.0047
55 EXOPHTHALMOS 10 0.0046
56 NEOPLASM SKIN 7 0.0045
57 CARBON DIOXIDE DECREASED 5 0.0043
58 PHYSICAL DISABILITY 19 0.0043
59 INFUSION SITE WARMTH 5 0.0041
60 CERVICAL SPINAL STENOSIS 7 0.0041
61 SPINAL COLUMN INJURY 9 0.0040
62 SPONDYLOLISTHESIS 7 0.0040
63 ASTIGMATISM 6 0.0040
64 JOINT ARTHROPLASTY 7 0.0039
65 ESSENTIAL HYPERTENSION 7 0.0038
66 AUTOIMMUNE THYROIDITIS 14 0.0037
67 RESPIRATORY ALKALOSIS 6 0.0037
68 TONGUE DISCOLOURATION 16 0.0037
69 MAST CELL ACTIVATION SYNDROME 5 0.0036
70 SPINAL OSTEOARTHRITIS 31 0.0035
71 DEVICE RELATED SEPSIS 7 0.0035
72 SEBORRHOEIC KERATOSIS 5 0.0034
73 GOITRE 14 0.0034
74 SPINAL STENOSIS 14 0.0034
75 EAR DISCOMFORT 34 0.0033
76 PROSTATOMEGALY 13 0.0033
77 PROSTATITIS 10 0.0033
78 GINGIVAL RECESSION 6 0.0031
79 ADJUSTMENT DISORDER 4 0.0031
80 JOINT NOISE 6 0.0031
81 SPINAL DEFORMITY 5 0.0030
82 HERPES VIRUS INFECTION 17 0.0029
83 CONCOMITANT DISEASE AGGRAVATED 18 0.0029
84 ACUTE SINUSITIS 5 0.0029
85 BREAST CYST 5 0.0028
86 ABSCESS INTESTINAL 6 0.0028
87 EXPOSED BONE IN JAW 6 0.0028
88 STRABISMUS 8 0.0027
89 HIGH DENSITY LIPOPROTEIN DECREASED 9 0.0027
90 ACTINIC KERATOSIS 7 0.0027
91 CHRONIC SINUSITIS 10 0.0027
92 TEMPOROMANDIBULAR JOINT SYNDROME 7 0.0026
93 ADRENAL DISORDER 5 0.0026
94 WEIGHT BEARING DIFFICULTY 7 0.0026
95 HEPATIC MASS 5 0.0026
96 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
97 AORTIC VALVE INCOMPETENCE 11 0.0026
98 NASAL SEPTUM DEVIATION 5 0.0026
99 JOINT CREPITATION 5 0.0025
100 LEARNING DISORDER 6 0.0025
101 BRONCHITIS CHRONIC 6 0.0025
102 TRIGGER FINGER 10 0.0024
103 CARTILAGE INJURY 6 0.0024
104 VASCULAR DEVICE INFECTION 11 0.0024
105 SCOLIOSIS 15 0.0024
106 SEASONAL ALLERGY 34 0.0024
107 OSTEITIS 6 0.0024
108 OESOPHAGEAL DISORDER 9 0.0023
109 LIPOMA 6 0.0023
110 INFUSION SITE BRUISING 5 0.0023
111 PSYCHOMOTOR SKILLS IMPAIRED 6 0.0023
112 TENDON PAIN 17 0.0022
113 NASAL POLYPS 11 0.0022
114 PLEURITIC PAIN 6 0.0022
115 SINUS PAIN 5 0.0021
116 TONGUE DISCOMFORT 9 0.0021
117 CONTRAST MEDIA REACTION 5 0.0021
118 SNORING 8 0.0021
119 MUSCLE TIGHTNESS 34 0.0021
120 SINUS OPERATION 5 0.0021
121 FINE MOTOR SKILL DYSFUNCTION 6 0.0021
122 PULMONARY PAIN 6 0.0021
123 OVERWEIGHT 11 0.0020
124 DECREASED INTEREST 12 0.0020
125 DIABETIC NEUROPATHY 10 0.0020
126 BLOOD THYROID STIMULATING HORMONE DECREASED 9 0.0020
127 APPLICATION SITE DISCOLOURATION 8 0.0020
128 MEAN CELL VOLUME INCREASED 5 0.0019
129 HYPERURICAEMIA 8 0.0019
130 MENOPAUSE 5 0.0019
131 BONE LESION 7 0.0019
132 BENIGN PROSTATIC HYPERPLASIA 10 0.0019
133 HEPATITIS TOXIC 5 0.0019
134 INFUSION SITE SWELLING 12 0.0019
135 FAECAL CALPROTECTIN INCREASED 6 0.0019
136 MUSCLE ATROPHY 24 0.0019
137 POLYMYALGIA RHEUMATICA 6 0.0019
138 ANAEMIA MACROCYTIC 4 0.0019
139 TINNITUS 86 0.0019
140 HERPES SIMPLEX 12 0.0018
141 VITAMIN D DEFICIENCY 18 0.0018
142 OSTEOPENIA 28 0.0018
143 MENISCUS INJURY 11 0.0018
144 METASTASES TO SPINE 6 0.0018
145 PRE-EXISTING CONDITION IMPROVED 11 0.0018
146 CARBOHYDRATE ANTIGEN 125 INCREASED 6 0.0018
147 BLOOD THYROID STIMULATING HORMONE INCREASED 16 0.0017
148 FIBULA FRACTURE 5 0.0017
149 SYNOVIAL CYST 8 0.0017
150 SPINAL PAIN 20 0.0017
151 JAUNDICE CHOLESTATIC 6 0.0017
152 PRODUCT CONTAMINATION 6 0.0017
153 RED CELL DISTRIBUTION WIDTH INCREASED 7 0.0017
154 MULTIPLE ALLERGIES 13 0.0017
155 SKIN LACERATION 18 0.0017
156 EAR PAIN 32 0.0016
157 PURULENT DISCHARGE 7 0.0016
158 MASTICATION DISORDER 5 0.0016
159 INFUSION SITE PAIN 21 0.0016
160 NAIL DISORDER 14 0.0016
161 BLOOD BLISTER 5 0.0016
162 ONYCHOCLASIS 11 0.0016
163 PROTEIN TOTAL DECREASED 6 0.0016
164 IRIDOCYCLITIS 5 0.0016
165 UPPER-AIRWAY COUGH SYNDROME 13 0.0016
166 DYSLIPIDAEMIA 8 0.0016
167 AORTIC ARTERIOSCLEROSIS 4 0.0016
168 ATELECTASIS 15 0.0016
169 LOOSE TOOTH 5 0.0016
170 VARICOSE VEIN 8 0.0015
171 MUSCLE SPASTICITY 19 0.0015
172 EXOSTOSIS 14 0.0015
173 IMPAIRED QUALITY OF LIFE 22 0.0015
174 BREAST ENLARGEMENT 5 0.0015
175 INFUSION SITE HAEMORRHAGE 5 0.0015
176 ECONOMIC PROBLEM 23 0.0015
177 THIRST 27 0.0015
178 INTERVERTEBRAL DISC PROTRUSION 33 0.0015
179 ANIMAL BITE 4 0.0015
180 PROSTATE CANCER METASTATIC 5 0.0015
181 FOOD POISONING 8 0.0015
182 PLANTAR FASCIITIS 5 0.0015
183 TONGUE ULCERATION 5 0.0015
184 HYDROCEPHALUS 8 0.0015
185 BRAIN FOG 23 0.0015
186 LARGE INTESTINE POLYP 10 0.0014
187 HAEMORRHOIDAL HAEMORRHAGE 7 0.0014
188 CAROTID ARTERY STENOSIS 5 0.0014
189 MITRAL VALVE INCOMPETENCE 16 0.0014
190 WHITE BLOOD CELL COUNT ABNORMAL 9 0.0014
191 GLOSSITIS 5 0.0014
192 VITAMIN D DECREASED 12 0.0014
193 NOCTURIA 17 0.0014
194 METASTATIC NEOPLASM 6 0.0014
195 HEPATIC LESION 6 0.0014
196 PATHOLOGICAL FRACTURE 7 0.0014
197 MONOCYTE COUNT INCREASED 5 0.0014
198 DIVERTICULUM INTESTINAL 6 0.0014
199 HYPOGAMMAGLOBULINAEMIA 9 0.0014
200 LIGAMENT RUPTURE 6 0.0014
201 TENDONITIS 21 0.0014
202 DENTAL CARIES 15 0.0014
203 FOOT DEFORMITY 15 0.0014
204 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
205 TENDON INJURY 5 0.0013
206 HYPERLIPIDAEMIA 16 0.0013
207 BLOOD PRESSURE SYSTOLIC INCREASED 26 0.0013
208 ROTATOR CUFF SYNDROME 17 0.0013
209 NEURALGIA 32 0.0013
210 SENSORY DISTURBANCE 21 0.0013
211 LYMPHOEDEMA 9 0.0013
212 OSTEOARTHRITIS 55 0.0013
213 NEPHROGENIC ANAEMIA 6 0.0013
214 DEFAECATION URGENCY 9 0.0013
215 ARTERIOSCLEROSIS 12 0.0013
216 SPINAL COLUMN STENOSIS 6 0.0013
217 PRODUCT USE COMPLAINT 20 0.0013
218 GESTATIONAL DIABETES 6 0.0013
219 SCIATICA 20 0.0013
220 AZOTAEMIA 5 0.0013
221 VENTRICULAR EXTRASYSTOLES 13 0.0013
222 FAECAL INCONTINENCE 6 0.0012
223 VISUAL FIELD DEFECT 9 0.0012
224 BLOOD CALCIUM DECREASED 14 0.0012
225 MUSCULOSKELETAL CHEST PAIN 19 0.0012
226 BODY TEMPERATURE DECREASED 12 0.0012
227 SKIN ATROPHY 7 0.0012
228 GASTROINTESTINAL SOUNDS ABNORMAL 6 0.0012
229 SPINAL COMPRESSION FRACTURE 10 0.0012
230 DECREASED ACTIVITY 13 0.0012
231 ATTENTION DEFICIT HYPERACTIVITY DISORDER 5 0.0012
232 HEAD DISCOMFORT 21 0.0012
233 TOOTH FRACTURE 13 0.0012
234 BOWEL MOVEMENT IRREGULARITY 9 0.0012
235 RIB FRACTURE 24 0.0012
236 PAIN IN JAW 33 0.0012
237 MUSCULOSKELETAL DISCOMFORT 20 0.0012
238 OCULAR DISCOMFORT 13 0.0012
239 BASAL CELL CARCINOMA 18 0.0012
240 AORTIC STENOSIS 4 0.0011
241 BLOOD ALBUMIN DECREASED 9 0.0011
242 GINGIVAL SWELLING 5 0.0011
243 RENAL PAIN 12 0.0011
244 DISCOMFORT 69 0.0011
245 RHINITIS ALLERGIC 5 0.0011
246 VITREOUS FLOATERS 11 0.0011
247 BLEPHAROSPASM 7 0.0011
248 SINUS CONGESTION 15 0.0011
249 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 6 0.0011
250 HYPERAESTHESIA 9 0.0011
251 SENSITIVE SKIN 8 0.0011
252 HIATUS HERNIA 14 0.0011
253 RENAL FUNCTION TEST ABNORMAL 5 0.0011
254 INTRACRANIAL PRESSURE INCREASED 6 0.0011
255 ROSACEA 5 0.0011
256 ORAL PAIN 24 0.0011
257 SINUS DISORDER 21 0.0011
258 EYE DISCHARGE 11 0.0011
259 APPETITE DISORDER 7 0.0011
260 TENDERNESS 11 0.0011
261 ERECTILE DYSFUNCTION 27 0.0011
262 RED BLOOD CELL COUNT DECREASED 30 0.0010
263 SLEEP APNOEA SYNDROME 20 0.0010
264 BLOOD MAGNESIUM DECREASED 9 0.0010
265 NEUROPATHY PERIPHERAL 99 0.0010
266 RENAL FAILURE CHRONIC 8 0.0010
267 THYROID DISORDER 16 0.0010
268 FOOD ALLERGY 8 0.0010
269 MUSCLE SPASMS 190 0.0010
270 SKIN WARM 6 0.0010
271 BLOOD TESTOSTERONE DECREASED 7 0.0010
272 FACIAL PAIN 9 0.0010
273 TRICUSPID VALVE INCOMPETENCE 8 0.0010
274 VEIN DISORDER 5 0.0010
275 MUSCULOSKELETAL DISORDER 19 0.0010
276 DRUG TOLERANCE 5 0.0010
277 GASTRITIS 26 0.0010
278 ORAL CANDIDIASIS 13 0.0010
279 TOOTH ABSCESS 10 0.0010
280 PHLEBITIS 5 0.0010
281 CARDIOMEGALY 12 0.0010
282 NERVE COMPRESSION 9 0.0010
283 OSTEONECROSIS OF JAW 24 0.0010
284 ANKLE FRACTURE 15 0.0010
285 COLD SWEAT 17 0.0010
286 DISABILITY 19 0.0010
287 NASAL DRYNESS 6 0.0010
288 WEIGHT FLUCTUATION 10 0.0010
289 SENSITIVITY TO WEATHER CHANGE 5 0.0009
290 FOOD CRAVING 5 0.0009
291 INFUSION SITE ERYTHEMA 8 0.0009
292 CHOLELITHIASIS 31 0.0009
293 EYE INFLAMMATION 9 0.0009
294 FOREIGN BODY SENSATION IN EYES 6 0.0009
295 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
296 SLEEP DISORDER 66 0.0009
297 SCAR 16 0.0009
298 CARDIAC FLUTTER 6 0.0009
299 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
300 BEHAVIOUR DISORDER 5 0.0009
301 DIPLOPIA 24 0.0009
302 DYSURIA 34 0.0009
303 EYE PAIN 52 0.0009
304 NORMAL NEWBORN 5 0.0009
305 CONJUNCTIVITIS 17 0.0009
306 INSURANCE ISSUE 14 0.0009
307 DYSPEPSIA 90 0.0009
308 HAEMATOCRIT DECREASED 18 0.0009
309 HYPERKERATOSIS 5 0.0009
310 PHOTOPHOBIA 17 0.0009
311 APHTHOUS ULCER 7 0.0009
312 FEELING COLD 25 0.0009
313 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
314 SINUSITIS 91 0.0009
315 PERIORBITAL SWELLING 5 0.0009
316 TOOTHACHE 16 0.0009
317 RENAL CYST 7 0.0009
318 PERONEAL NERVE PALSY 5 0.0009
319 GINGIVAL PAIN 7 0.0009
320 GENERALISED ERYTHEMA 5 0.0009
321 ATRIAL FLUTTER 7 0.0009
322 INITIAL INSOMNIA 9 0.0009
323 DERMATITIS CONTACT 10 0.0009
324 MICTURITION URGENCY 10 0.0009
325 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
326 PROSTATIC SPECIFIC ANTIGEN INCREASED 12 0.0009
327 SENSORY LOSS 7 0.0009
328 INCREASED TENDENCY TO BRUISE 8 0.0009
329 NIGHT SWEATS 28 0.0009
330 EXERCISE TOLERANCE DECREASED 5 0.0009
331 RHINITIS 7 0.0009
332 HAIR GROWTH ABNORMAL 6 0.0009
333 BLOOD URIC ACID INCREASED 5 0.0009
334 FLANK PAIN 8 0.0009
335 HYPOTHYROIDISM 27 0.0008
336 FLUID RETENTION 43 0.0008
337 RESPIRATORY TRACT INFECTION 22 0.0008
338 BLOOD IRON DECREASED 10 0.0008
339 JOINT INJURY 18 0.0008
340 SINUS HEADACHE 5 0.0008
341 TONGUE DISORDER 6 0.0008
342 HYPERCHOLESTEROLAEMIA 8 0.0008
343 EAR INFECTION 22 0.0008
344 MUSCLE TWITCHING 19 0.0008
345 PANIC ATTACK 30 0.0008
346 NECK PAIN 46 0.0008
347 DRY EYE 41 0.0008
348 ORAL HERPES 16 0.0008
349 GASTROINTESTINAL PAIN 9 0.0008
350 SKIN ULCER 21 0.0008
351 HYPOPHOSPHATAEMIA 6 0.0008
352 SKIN HAEMORRHAGE 12 0.0008
353 BLOOD PRESSURE ABNORMAL 16 0.0008
354 UPPER RESPIRATORY TRACT INFECTION 37 0.0008
355 C-REACTIVE PROTEIN INCREASED 29 0.0008
356 LYMPHADENOPATHY 28 0.0008
357 AORTIC ANEURYSM 6 0.0008
358 TROPONIN INCREASED 6 0.0008
359 BLOOD TEST ABNORMAL 11 0.0008
360 PERICARDIAL EFFUSION 18 0.0008
361 OROPHARYNGEAL PAIN 72 0.0008
362 URINARY INCONTINENCE 23 0.0008
363 MADAROSIS 9 0.0008
364 VASCULITIS 9 0.0008
365 GASTROOESOPHAGEAL REFLUX DISEASE 62 0.0008
366 CANDIDA INFECTION 13 0.0008
367 HAEMORRHOIDS 15 0.0008
368 TENDON DISORDER 5 0.0008
369 BLOOD POTASSIUM DECREASED 23 0.0008
370 POLYP 5 0.0008
371 ANHEDONIA 20 0.0008
372 EYE DISORDER 25 0.0008
373 PNEUMOTHORAX 12 0.0008
374 MACULAR DEGENERATION 9 0.0008
375 EATING DISORDER 16 0.0008
376 WRIST FRACTURE 9 0.0008
377 BLOOD PRESSURE FLUCTUATION 18 0.0007
378 DEFORMITY 7 0.0007
379 ASCITES 22 0.0007
380 BODY HEIGHT DECREASED 8 0.0007
381 MUSCULAR WEAKNESS 85 0.0007
382 TERMINAL STATE 5 0.0007
383 PRODUCT SUBSTITUTION ISSUE 43 0.0007
384 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
385 QUALITY OF LIFE DECREASED 10 0.0007
386 BREAST MASS 5 0.0007
387 POOR QUALITY SLEEP 16 0.0007
388 MYASTHENIA GRAVIS 6 0.0007
389 BRONCHIECTASIS 5 0.0007
390 IMMUNODEFICIENCY 11 0.0007
391 CONTUSION 71 0.0007
392 GINGIVAL BLEEDING 10 0.0007
393 NASAL CONGESTION 43 0.0007
394 ECCHYMOSIS 5 0.0007
395 BALANCE DISORDER 63 0.0007
396 LACRIMATION INCREASED 22 0.0007
397 HAIR DISORDER 6 0.0007
398 MUSCULOSKELETAL PAIN 38 0.0007
399 JOINT EFFUSION 5 0.0007
400 GOUT 13 0.0007
401 ERUCTATION 14 0.0007
402 MYALGIA 123 0.0007
403 RED BLOOD CELL SEDIMENTATION RATE INCREASED 8 0.0007
404 INSOMNIA 192 0.0007
405 AUTOIMMUNE DISORDER 7 0.0007
406 OSTEOMYELITIS 13 0.0007
407 FEELING HOT 44 0.0007
408 BLOOD UREA INCREASED 12 0.0007
409 HOT FLUSH 54 0.0007
410 DEVICE RELATED INFECTION 11 0.0007
411 THERAPEUTIC PRODUCT EFFECT DECREASED 32 0.0007
412 PERIPHERAL SWELLING 110 0.0007
413 BONE DISORDER 13 0.0007
414 END STAGE RENAL DISEASE 13 0.0007
415 MIGRAINE 68 0.0007
416 MOUTH ULCERATION 15 0.0007
417 THERAPY CHANGE 7 0.0007
418 STOMATITIS 43 0.0007
419 EYE INFECTION 8 0.0007
420 LYMPHOPENIA 10 0.0007
421 JAUNDICE 19 0.0007
422 RETCHING 15 0.0007
423 FREQUENT BOWEL MOVEMENTS 19 0.0007
424 IMPAIRED WORK ABILITY 15 0.0007
425 PRODUCT SUPPLY ISSUE 5 0.0007
426 BONE PAIN 41 0.0007
427 PSEUDOMONAS INFECTION 6 0.0007
428 FIBROMYALGIA 17 0.0007
429 PARAESTHESIA 110 0.0007
430 LIVER FUNCTION TEST INCREASED 15 0.0007
431 NEPHROLITHIASIS 32 0.0007
432 POLLAKIURIA 29 0.0007
433 CARDIAC MURMUR 6 0.0007
434 PARAESTHESIA ORAL 10 0.0007
435 PALPITATIONS 81 0.0007
436 OBESITY 11 0.0007
437 DRY MOUTH 56 0.0007
438 BLOOD SODIUM DECREASED 13 0.0007
439 BRONCHITIS 51 0.0007
440 FLATULENCE 39 0.0007
441 FAECES SOFT 5 0.0007
442 URINE OUTPUT DECREASED 6 0.0007
443 DISTURBANCE IN ATTENTION 37 0.0007
444 FOOT FRACTURE 13 0.0007
445 BLOOD CALCIUM INCREASED 6 0.0007
446 EUPHORIC MOOD 7 0.0007
447 ORAL DISORDER 5 0.0007
448 GRIP STRENGTH DECREASED 6 0.0007
449 FLUSHING 69 0.0007
450 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
451 EYE HAEMORRHAGE 9 0.0007
452 BACTERAEMIA 8 0.0007
453 CHEST DISCOMFORT 69 0.0007
454 FEELING DRUNK 5 0.0007
455 HAIR TEXTURE ABNORMAL 9 0.0007
456 HERNIA 13 0.0007
457 CHOLECYSTITIS 8 0.0007
458 JOINT SWELLING 81 0.0007
459 PETECHIAE 7 0.0007
460 GASTROINTESTINAL INFECTION 6 0.0007
461 SNEEZING 15 0.0007
462 PAIN IN EXTREMITY 197 0.0007
463 HYPOAESTHESIA 100 0.0007
464 TRANSFUSION 7 0.0007
465 DYSPHONIA 39 0.0007
466 OROPHARYNGEAL DISCOMFORT 6 0.0007
467 DYSPNOEA EXERTIONAL 25 0.0007
468 PAROSMIA 5 0.0007
469 VISUAL ACUITY REDUCED 22 0.0007
470 BURSITIS 8 0.0007
471 ATRIAL FIBRILLATION 64 0.0007
472 OSTEOPOROSIS 27 0.0007
473 BURNING SENSATION 46 0.0007
474 PERIPHERAL COLDNESS 9 0.0007
475 DEAFNESS 17 0.0006
476 DIVERTICULITIS 18 0.0006
477 JOINT STIFFNESS 17 0.0006
478 TENDON RUPTURE 8 0.0006
479 ARTHROPATHY 36 0.0006
480 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
481 FAECES DISCOLOURED 14 0.0006
482 HAEMOPTYSIS 18 0.0006
483 WEIGHT DECREASED 180 0.0006
484 LETHARGY 37 0.0006
485 WEIGHT INCREASED 144 0.0006
486 CARPAL TUNNEL SYNDROME 9 0.0006
487 ARTHRALGIA 267 0.0006
488 TASTE DISORDER 13 0.0006
489 OESOPHAGITIS 7 0.0006
490 PLATELET COUNT DECREASED 68 0.0006
491 SQUAMOUS CELL CARCINOMA 6 0.0006
492 BACK PAIN 148 0.0006
493 FATIGUE 495 0.0006
494 ARTHRITIS 50 0.0006
495 SPUTUM DISCOLOURED 6 0.0006
496 NASAL DISCOMFORT 5 0.0006
497 ANXIETY 179 0.0006
498 ULCER 10 0.0006
499 ALOPECIA 123 0.0006
500 SKIN INFECTION 7 0.0006
501 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
502 HYPERTHYROIDISM 9 0.0006
503 SINUS BRADYCARDIA 6 0.0006
504 STENT PLACEMENT 5 0.0006
505 DIZZINESS POSTURAL 6 0.0006
506 ABNORMAL DREAMS 17 0.0006
507 POST PROCEDURAL INFECTION 5 0.0006
508 ABDOMINAL DISTENSION 64 0.0006
509 GAIT DISTURBANCE 117 0.0006
510 LIVER INJURY 15 0.0006
511 LABORATORY TEST ABNORMAL 18 0.0006
512 METASTASES TO BONE 10 0.0006
513 WHITE BLOOD CELL COUNT DECREASED 66 0.0006
514 BLOOD PRESSURE INCREASED 93 0.0006
515 IRRITABLE BOWEL SYNDROME 13 0.0006
516 BLADDER DISORDER 6 0.0006
517 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
518 EPISTAXIS 45 0.0006
519 AGEUSIA 15 0.0006
520 SKIN DISORDER 20 0.0006
521 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
522 SPLENOMEGALY 7 0.0006
523 INJURY 42 0.0006
524 HYPOXIA 21 0.0006
525 CELLULITIS 30 0.0006
526 EMPHYSEMA 6 0.0006
527 EMOTIONAL DISTRESS 72 0.0006
528 FEELING ABNORMAL 142 0.0006
529 NEUTROPHIL COUNT INCREASED 6 0.0006
530 AMNESIA 38 0.0006
531 HAEMATURIA 20 0.0006
532 LYMPHOMA 9 0.0006
533 MUSCULOSKELETAL STIFFNESS 51 0.0006
534 MUSCLE STRAIN 5 0.0006
535 PYELONEPHRITIS 5 0.0006
536 SWOLLEN TONGUE 18 0.0006
537 LOCAL SWELLING 10 0.0006
538 CYANOSIS 9 0.0006
539 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
540 HEART RATE DECREASED 20 0.0006
541 FULL BLOOD COUNT ABNORMAL 6 0.0006
542 LUNG INFILTRATION 5 0.0006
543 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
544 SKIN DISCOLOURATION 26 0.0006
545 VISUAL IMPAIRMENT 70 0.0006
546 HAIR COLOUR CHANGES 7 0.0006
547 SUBDURAL HAEMATOMA 8 0.0006
548 COVID-19 98 0.0006
549 HEADACHE 350 0.0006
550 PAIN OF SKIN 15 0.0006
551 DERMATITIS ALLERGIC 7 0.0006
552 HAEMOGLOBIN DECREASED 57 0.0006
553 BLOOD POTASSIUM INCREASED 9 0.0006
554 DEVELOPMENTAL DELAY 5 0.0006
555 GASTROENTERITIS VIRAL 10 0.0006
556 BACK DISORDER 9 0.0006
557 ANOSMIA 8 0.0006
558 PALLOR 15 0.0006
559 RESTLESS LEGS SYNDROME 10 0.0005
560 OEDEMA PERIPHERAL 67 0.0005
561 STAPHYLOCOCCAL INFECTION 18 0.0005
562 CONSTIPATION 119 0.0005
563 VIRAL INFECTION 18 0.0005
564 BODY TEMPERATURE INCREASED 11 0.0005
565 PULMONARY MASS 8 0.0005
566 HEPATIC STEATOSIS 10 0.0005
567 ABDOMINAL DISCOMFORT 90 0.0005
568 MALNUTRITION 6 0.0005
569 BLOOD CHOLESTEROL INCREASED 25 0.0005
570 NERVOUSNESS 28 0.0005
571 NEPHROPATHY 5 0.0005
572 HEART RATE INCREASED 53 0.0005
573 OEDEMA 29 0.0005
574 PRESYNCOPE 13 0.0005
575 TYPE 2 DIABETES MELLITUS 18 0.0005
576 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
577 URINARY TRACT INFECTION 91 0.0005
578 BONE LOSS 8 0.0005
579 COUGH 149 0.0005
580 HEART RATE IRREGULAR 12 0.0005
581 HYPOAESTHESIA ORAL 8 0.0005
582 TOOTH LOSS 11 0.0005
583 SARS-COV-2 TEST POSITIVE 7 0.0005
584 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
585 INFLUENZA 59 0.0005
586 PULMONARY HYPERTENSION 11 0.0005
587 DYSMENORRHOEA 7 0.0005
588 IMPAIRED DRIVING ABILITY 6 0.0005
589 RHINORRHOEA 34 0.0005
590 ANGINA PECTORIS 15 0.0005
591 NEOPLASM 6 0.0005
592 DIZZINESS 260 0.0005
593 HALLUCINATION, VISUAL 11 0.0005
594 CATARACT 31 0.0005
595 EMOTIONAL DISORDER 16 0.0005
596 INFECTION 75 0.0005
597 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
598 LIMB DISCOMFORT 16 0.0005
599 ILLNESS 53 0.0005
600 COGNITIVE DISORDER 24 0.0005
601 DYSSTASIA 15 0.0005
602 EOSINOPHILIA 9 0.0005
603 IMPAIRED GASTRIC EMPTYING 7 0.0005
604 NERVOUS SYSTEM DISORDER 16 0.0005
605 CHOKING 10 0.0005
606 SKIN FISSURES 10 0.0005
607 DIARRHOEA 330 0.0005
608 KIDNEY INFECTION 10 0.0005
609 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
610 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
611 LYMPHOCYTE COUNT DECREASED 9 0.0005
612 PRURITUS GENERALISED 11 0.0005
613 ASPARTATE AMINOTRANSFERASE INCREASED 27 0.0005
614 NASOPHARYNGITIS 93 0.0005
615 ORAL DISCOMFORT 7 0.0005
616 HYPOMAGNESAEMIA 7 0.0005
617 PRODUCTIVE COUGH 24 0.0005
618 GASTROINTESTINAL DISORDER 45 0.0005
619 SEIZURE 58 0.0005
620 ROAD TRAFFIC ACCIDENT 21 0.0005
621 APHONIA 7 0.0005
622 ABSCESS 8 0.0005
623 BRAIN INJURY 5 0.0005
624 HYPERHIDROSIS 64 0.0005
625 MUCOSAL INFLAMMATION 13 0.0005
626 BLINDNESS UNILATERAL 7 0.0005
627 LOCALISED INFECTION 12 0.0005
628 CHILLS 58 0.0005
629 RASH PAPULAR 11 0.0005
630 MOTOR DYSFUNCTION 5 0.0005
631 ABDOMINAL PAIN UPPER 101 0.0005
632 ASTHENIA 184 0.0005
633 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
634 HYPERSOMNIA 14 0.0005
635 HYPOACUSIS 21 0.0005
636 SMALL INTESTINAL OBSTRUCTION 6 0.0005
637 IMPAIRED HEALING 16 0.0005
638 HYPERCALCAEMIA 6 0.0005
639 TEMPERATURE INTOLERANCE 5 0.0005
640 INFLAMMATION 25 0.0005
641 PHARYNGITIS 6 0.0005
642 MIDDLE INSOMNIA 9 0.0005
643 LIVER FUNCTION TEST ABNORMAL 14 0.0005
644 COAGULOPATHY 8 0.0005
645 APATHY 7 0.0005
646 DEPRESSION 109 0.0005
647 SECRETION DISCHARGE 6 0.0005
648 LIMB INJURY 13 0.0005
649 EYE PRURITUS 16 0.0005
650 VERTIGO 29 0.0005
651 PAIN 291 0.0005
652 GASTRIC ULCER 9 0.0005
653 VISION BLURRED 65 0.0005
654 INCONTINENCE 5 0.0005
655 FEELING JITTERY 9 0.0005
656 HEMIPARESIS 8 0.0005
657 DRY SKIN 63 0.0005
658 DYSGEUSIA 35 0.0005
659 CYSTITIS 15 0.0005
660 COLITIS ULCERATIVE 21 0.0005
661 INTRAOCULAR PRESSURE INCREASED 6 0.0005
662 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
663 DECREASED APPETITE 108 0.0005
664 APHASIA 14 0.0005
665 SKIN EXFOLIATION 39 0.0005
666 RASH PRURITIC 25 0.0005
667 MULTIPLE SCLEROSIS 22 0.0005
668 NODULE 6 0.0005
669 ASPIRATION 5 0.0005
670 BLOOD GLUCOSE FLUCTUATION 5 0.0005
671 METASTASES TO LIVER 8 0.0005
672 CHEST PAIN 84 0.0005
673 BLOOD PRESSURE DECREASED 30 0.0005
674 PRESCRIBED UNDERDOSE 9 0.0005
675 TACHYCARDIA 40 0.0004
676 NERVE INJURY 5 0.0004
677 INFLUENZA LIKE ILLNESS 37 0.0004
678 SEPSIS 50 0.0004
679 MENINGIOMA 7 0.0004
680 SUICIDAL IDEATION 41 0.0004
681 GLOSSODYNIA 10 0.0004
682 NEPHROPATHY TOXIC 5 0.0004
683 FISTULA 5 0.0004
684 ANAL INCONTINENCE 4 0.0004
685 PLEURAL EFFUSION 27 0.0004
686 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
687 RESPIRATORY TRACT CONGESTION 7 0.0004
688 FALL 146 0.0004
689 SCAB 5 0.0004
690 METABOLIC ACIDOSIS 14 0.0004
691 INTERNAL HAEMORRHAGE 5 0.0004
692 SKIN LESION 12 0.0004
693 GASTRIC DISORDER 15 0.0004
694 HIP FRACTURE 14 0.0004
695 CHRONIC KIDNEY DISEASE 33 0.0004
696 IRRITABILITY 26 0.0004
697 ELECTROLYTE IMBALANCE 5 0.0004
698 EYE SWELLING 16 0.0004
699 ANAEMIA 82 0.0004
700 BACTERIAL INFECTION 8 0.0004
701 LUNG DISORDER 21 0.0004
702 ERYTHEMA 88 0.0004
703 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
704 INFUSION RELATED REACTION 28 0.0004
705 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
706 ATAXIA 5 0.0004
707 BRONCHOSPASM 6 0.0004
708 PSORIATIC ARTHROPATHY 17 0.0004
709 INCREASED APPETITE 8 0.0004
710 PULMONARY FIBROSIS 8 0.0004
711 EYE IRRITATION 24 0.0004
712 PRURITUS 160 0.0004
713 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
714 GLAUCOMA 8 0.0004
715 BONE DENSITY DECREASED 13 0.0004
716 MEMORY IMPAIRMENT 57 0.0004
717 INJECTION SITE HAEMATOMA 6 0.0004
718 DEHYDRATION 55 0.0004
719 FLUID OVERLOAD 6 0.0004
720 ADRENAL INSUFFICIENCY 5 0.0004
721 PANCYTOPENIA 23 0.0004
722 FEAR 11 0.0004
723 AGITATION 30 0.0004
724 MOOD SWINGS 13 0.0004
725 FEBRILE NEUTROPENIA 27 0.0004
726 LIVER DISORDER 18 0.0004
727 TOOTH DISORDER 9 0.0004
728 GENERALISED OEDEMA 5 0.0004
729 TREMOR 67 0.0004
730 TOOTH EXTRACTION 5 0.0004
731 RESPIRATORY DISORDER 12 0.0004
732 NAUSEA 317 0.0004
733 OCULAR HYPERAEMIA 19 0.0004
734 PNEUMONIA ASPIRATION 10 0.0004
735 SPINAL FRACTURE 8 0.0004
736 DEPRESSED MOOD 21 0.0004
737 HYPERTENSION 84 0.0004
738 UNEVALUABLE EVENT 30 0.0004
739 HEPATIC ENZYME INCREASED 27 0.0004
740 PRODUCT ADMINISTRATION ERROR 8 0.0004
741 BLINDNESS 16 0.0004
742 EPILEPSY 12 0.0004
743 SYNCOPE 39 0.0004
744 MOBILITY DECREASED 28 0.0004
745 SOMNOLENCE 78 0.0004
746 LEUKOCYTOSIS 7 0.0004
747 RASH GENERALISED 10 0.0004
748 THERAPY PARTIAL RESPONDER 6 0.0004
749 PLATELET COUNT INCREASED 5 0.0004
750 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
751 MALIGNANT NEOPLASM PROGRESSION 39 0.0004
752 HAEMATOCHEZIA 21 0.0004
753 PULMONARY CONGESTION 5 0.0004
754 BLOOD GLUCOSE ABNORMAL 7 0.0004
755 THINKING ABNORMAL 7 0.0004
756 JOINT RANGE OF MOTION DECREASED 5 0.0004
757 PSYCHOTIC DISORDER 11 0.0004
758 SKIN CANCER 8 0.0004
759 HYPOCALCAEMIA 7 0.0004
760 THROAT TIGHTNESS 10 0.0004
761 SWELLING FACE 24 0.0004
762 HYPOKALAEMIA 17 0.0004
763 DYSPNOEA 208 0.0004
764 PNEUMONITIS 10 0.0004
765 ENCEPHALOPATHY 9 0.0004
766 PNEUMONIA 118 0.0004
767 LOWER LIMB FRACTURE 7 0.0004
768 ACUTE RESPIRATORY FAILURE 7 0.0004
769 PHOTOSENSITIVITY REACTION 6 0.0004
770 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
771 PROCEDURAL PAIN 10 0.0004
772 THROMBOSIS 29 0.0004
773 PRODUCT DOSE OMISSION ISSUE 106 0.0004
774 LIP SWELLING 12 0.0004
775 RASH 157 0.0004
776 ARRHYTHMIA 17 0.0004
777 HUNGER 5 0.0004
778 COORDINATION ABNORMAL 5 0.0004
779 DRUG ADMINISTRATION ERROR 11 0.0004
780 DYSPHAGIA 34 0.0004
781 ABDOMINAL PAIN 83 0.0004
782 BLISTER 20 0.0004
783 OXYGEN SATURATION DECREASED 20 0.0004
784 PYREXIA 123 0.0004
785 HYPONATRAEMIA 20 0.0004
786 DISORIENTATION 14 0.0004
787 SWELLING 33 0.0004
788 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
789 INJECTION SITE MASS 13 0.0004
790 UPPER LIMB FRACTURE 7 0.0004
791 INTENTIONAL DOSE OMISSION 10 0.0004
792 HYPERSENSITIVITY 65 0.0003
793 PARALYSIS 5 0.0003
794 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
795 ASTHMA 39 0.0003
796 RHEUMATOID ARTHRITIS 39 0.0003
797 LOSS OF CONSCIOUSNESS 44 0.0003
798 COLITIS 13 0.0003
799 HYPERKALAEMIA 12 0.0003
800 BLOOD GLUCOSE INCREASED 64 0.0003
801 RENAL FAILURE 45 0.0003
802 DEEP VEIN THROMBOSIS 22 0.0003
803 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 61 0.0003
804 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
805 WHEEZING 20 0.0003
806 BLOOD CREATININE INCREASED 22 0.0003
807 GALLBLADDER DISORDER 6 0.0003
808 PRODUCT PRESCRIBING ERROR 8 0.0003
809 FUNGAL INFECTION 11 0.0003
810 MOOD ALTERED 9 0.0003
811 BLOOD COUNT ABNORMAL 5 0.0003
812 URINARY RETENTION 11 0.0003
813 GAIT INABILITY 11 0.0003
814 HYPOTENSION 66 0.0003
815 CONFUSIONAL STATE 53 0.0003
816 CARDIAC FAILURE 26 0.0003
817 ABASIA 8 0.0003
818 WOUND 9 0.0003
819 DELUSION 5 0.0003
820 EJECTION FRACTION DECREASED 5 0.0003
821 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
822 CARDIAC DISORDER 30 0.0003
823 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
824 HEPATIC CIRRHOSIS 6 0.0003
825 NIGHTMARE 11 0.0003
826 NEOPLASM PROGRESSION 11 0.0003
827 BLOOD URINE PRESENT 6 0.0003
828 PRODUCT COMPLAINT 8 0.0003
829 PROTEINURIA 6 0.0003
830 RASH MACULAR 11 0.0003
831 HEPATOTOXICITY 7 0.0003
832 HERPES ZOSTER 18 0.0003
833 HYPOPHAGIA 8 0.0003
834 ILL-DEFINED DISORDER 19 0.0003
835 VOMITING 147 0.0003
836 POST PROCEDURAL COMPLICATION 6 0.0003
837 CONDITION AGGRAVATED 95 0.0003
838 THROAT IRRITATION 14 0.0003
839 THERAPY CESSATION 16 0.0003
840 THERAPY NON-RESPONDER 14 0.0003
841 PANCREATITIS ACUTE 7 0.0003
842 PRODUCT QUALITY ISSUE 42 0.0003
843 DRUG INTERACTION 49 0.0003
844 MANIA 5 0.0003
845 LEUKOPENIA 15 0.0003
846 MENTAL DISORDER 13 0.0003
847 MALAISE 131 0.0003
848 URTICARIA 50 0.0003
849 PRODUCT USE ISSUE 56 0.0003
850 RENAL IMPAIRMENT 25 0.0003
851 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
852 BLOOD BILIRUBIN INCREASED 8 0.0003
853 FEEDING DISORDER 6 0.0003
854 ANGER 10 0.0003
855 THROMBOCYTOPENIA 33 0.0003
856 RASH ERYTHEMATOUS 14 0.0003
857 INJECTION SITE WARMTH 6 0.0003
858 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
859 SURGERY 17 0.0003
860 ADVERSE DRUG REACTION 26 0.0003
861 DIABETES MELLITUS 22 0.0003
862 ACUTE KIDNEY INJURY 44 0.0003
863 ORTHOSTATIC HYPOTENSION 5 0.0003
864 ECZEMA 15 0.0003
865 DERMATITIS 6 0.0003
866 SPEECH DISORDER 15 0.0003
867 GENERAL PHYSICAL HEALTH DETERIORATION 33 0.0003
868 HEAD INJURY 9 0.0003
869 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
870 MOVEMENT DISORDER 9 0.0003
871 DRUG INTOLERANCE 27 0.0003
872 RECTAL HAEMORRHAGE 12 0.0003
873 HAEMORRHAGE 29 0.0003
874 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
875 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
876 PRODUCT PRESCRIBING ISSUE 6 0.0003
877 PULMONARY EMBOLISM 26 0.0003
878 HEPATITIS 7 0.0003
879 HAEMATOMA 7 0.0003
880 RENAL INJURY 8 0.0003
881 PULMONARY OEDEMA 12 0.0003
882 CHROMATURIA 6 0.0003
883 APPLICATION SITE PRURITUS 6 0.0003
884 CORONARY ARTERY DISEASE 8 0.0003
885 INJECTION SITE BRUISING 21 0.0003
886 INTENTIONAL PRODUCT MISUSE 23 0.0003
887 BREAST CANCER FEMALE 7 0.0003
888 AGGRESSION 13 0.0003
889 RENAL FAILURE ACUTE 11 0.0003
890 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
891 RENAL DISORDER 12 0.0003
892 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
893 ABNORMAL BEHAVIOUR 10 0.0003
894 MENTAL STATUS CHANGES 7 0.0003
895 THERAPY INTERRUPTED 18 0.0003
896 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
897 FULL BLOOD COUNT DECREASED 5 0.0002
898 INJECTION SITE SWELLING 19 0.0002
899 RESTLESSNESS 9 0.0002
900 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
901 NEUTROPHIL COUNT DECREASED 10 0.0002
902 DISEASE PROGRESSION 29 0.0002
903 NEEDLE ISSUE 7 0.0002
904 INJECTION SITE PRURITUS 16 0.0002
905 INTESTINAL OBSTRUCTION 9 0.0002
906 WITHDRAWAL SYNDROME 10 0.0002
907 ABDOMINAL PAIN LOWER 6 0.0002
908 PLASMA CELL MYELOMA 9 0.0002
909 BLOOD GLUCOSE DECREASED 11 0.0002
910 AMENORRHOEA 4 0.0002
911 OFF LABEL USE 198 0.0002
912 FEMUR FRACTURE 7 0.0002
913 PRODUCT USE IN UNAPPROVED INDICATION 56 0.0002
914 INJECTION SITE ERYTHEMA 28 0.0002
915 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
916 CARDIAC FAILURE CONGESTIVE 18 0.0002
917 DRUG EFFECT INCOMPLETE 8 0.0002
918 CRYING 8 0.0002
919 LUNG NEOPLASM MALIGNANT 9 0.0002
920 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
921 SKIN IRRITATION 10 0.0002
922 RESPIRATORY DISTRESS 6 0.0002
923 PRODUCT DOSE OMISSION 14 0.0002
924 HALLUCINATION 16 0.0002
925 PANCREATITIS 11 0.0002
926 BRADYCARDIA 11 0.0002
927 SEPTIC SHOCK 9 0.0002
928 TREATMENT NONCOMPLIANCE 11 0.0002
929 THERAPEUTIC RESPONSE DECREASED 12 0.0002
930 SUICIDE ATTEMPT 12 0.0002
931 ACNE 15 0.0002
932 CARDIOVASCULAR DISORDER 5 0.0002
933 DYSKINESIA 8 0.0002
934 TREATMENT FAILURE 16 0.0002
935 HYPERGLYCAEMIA 7 0.0002
936 DRUG-INDUCED LIVER INJURY 6 0.0002
937 SEDATION 5 0.0002
938 DISEASE RECURRENCE 9 0.0002
939 CEREBROVASCULAR ACCIDENT 32 0.0002
940 DRUG INEFFECTIVE 246 0.0002
941 DYSARTHRIA 7 0.0002
942 INJECTION SITE PAIN 57 0.0002
943 VAGINAL HAEMORRHAGE 8 0.0002
944 NEUTROPENIA 25 0.0002
945 PSORIASIS 24 0.0002
946 CARDIAC ARREST 15 0.0002
947 INCORRECT DOSE ADMINISTERED 40 0.0002
948 INJECTION SITE REACTION 12 0.0002
949 MYOCARDIAL INFARCTION 30 0.0002
950 ACUTE MYOCARDIAL INFARCTION 5 0.0002
951 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
952 SKIN BURNING SENSATION 12 0.0002
953 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
954 INTERSTITIAL LUNG DISEASE 8 0.0002
955 NEOPLASM MALIGNANT 11 0.0002
956 RESPIRATORY FAILURE 12 0.0002
957 ANAPHYLACTIC REACTION 9 0.0002
958 CONVULSION 9 0.0002
959 DRUG DOSE OMISSION 26 0.0002
960 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 31 0.0002
961 DERMATITIS ATOPIC 8 0.0002
962 INJECTION SITE HAEMORRHAGE 12 0.0002
963 BREAST CANCER 14 0.0002
964 ABORTION SPONTANEOUS 6 0.0001
965 DELIRIUM 5 0.0001
966 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
967 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
968 DEATH 114 0.0001
969 HOSPITALISATION 20 0.0001
970 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
971 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
972 PROSTATE CANCER 10 0.0001
973 EXTRA DOSE ADMINISTERED 5 0.0001
974 ADVERSE EVENT 11 0.0001
975 TOXICITY TO VARIOUS AGENTS 20 0.0001
976 DEVICE MALFUNCTION 8 0.0001
977 UNDERDOSE 8 0.0001
978 OVERDOSE 23 0.0001
979 COMA 5 0.0001
980 HYPOGLYCAEMIA 5 0.0001
981 EXPOSURE DURING PREGNANCY 6 0.0001
982 DRUG EFFECT DECREASED 5 0.0001
983 PRODUCT STORAGE ERROR 8 0.0001
984 DEVICE ISSUE 8 0.0001
985 NO ADVERSE EVENT 15 0.0001
986 DRUG WITHDRAWAL SYNDROME 7 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
988 DEVICE DIFFICULT TO USE 5 0.0001
989 DRUG DEPENDENCE 7 0.0000